FIM
AMED

Freedom Investment Management’s Amedisys AMED Stock Holding History

Freedom Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,135
Closed -$300K – 870
2021
Q1 		$300K Buy
1,135
+118
+12% +$33.3K 0.02% 673
2020
Q4 		$298K Sell
1,017
-60
-6% -$15.4K 0.03% 474
2020
Q3 		$255K Sell
1,077
-310
-22% -$70.5K 0.03% 450
2020
Q2 		$275K Sell
1,387
-894
-39% -$167K 0.03% 426
2020
Q1 		$431K Buy
+2,281
New +$406K 0.04% 381
2019
Q4 		– Sell
-2,694
Closed -$353K – 666
2019
Q3 		$353K Sell
2,694
-589
-18% -$76.7K 0.03% 450
2019
Q2 		$399K Buy
+3,283
New +$390K 0.03% 424
2019
Q1 		– Sell
-4,443
Closed -$520K – 686
2018
Q4 		$520K Sell
4,443
-615
-12% -$72.5K 0.04% 414
2018
Q3 		$632K Sell
5,058
-2,777
-35% -$307K 0.04% 445
2018
Q2 		$670K Sell
7,835
-3,633
-32% -$267K 0.04% 445
2018
Q1 		$692K Buy
+11,468
New +$653K 0.04% 500

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Freedom Investment Management's AMED Position: Q2 2021 in Review

Freedom Investment Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,135 shares — an estimated $300K sold.

Freedom Investment Management first reported a position in AMED in Q1 2018 and held it in 11 quarters. The position peaked at $692K in Q1 2018. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Freedom Investment Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Freedom Investment Management sold 1,135 Amedisys shares in Q2 2021, an estimated $300K.
  • Freedom Investment Management first reported a position in Amedisys in Q1 2018 and held it in 11 quarters.
  • Freedom Investment Management's Amedisys position peaked at $692K in Q1 2018.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Freedom Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.